Ureteral stone
Conditions
Interventions
Take Saireito orally
Not to be taken internally
Sponsors
Kansai Medical University, Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with ureteral stone and hydronephrosis before transurethral ureterolithotripsy (TUL)
Exclusion criteria
Exclusion criteria: 1)Patients treated bilateral upper tract stone at one stage procedure 2)Patients with thinning of the kidney 3)Patients emerges febrile urinary tract infection after procedure 4)Difficulty of communication 5)When doctor had judged the patients need stent for a long time 6)When doctor had judged the patients disqualified as a subject of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison with the ratio of the area in hydronephrosis to the area of kidney in the largest cross-sectional slice using ultrasonography between two groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Comparison with stent related pain on stent removal between two groups 2)Comparison with grade of hydronephrosis between two groups 3)Comparison with psychological well-being on stent removal between two groups 4)Comparison with OABSS(Overactive bladder symptom score) and IPSS(International Prostate Symptom Score)on stent removal between two groups 5)Comparison with quantity and frequency of analgestic drug on stent removal between two groups 6)Comparison with complication between two groups | — |
Countries
Japan
Contacts
Public ContactJunichi Ikeda
Kansai Medical University, Medical Center Urology
Outcome results
None listed